Anatomic Pathology Market - Top Companies and Manufacturers

  • Report ID: 4377
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Companies Dominating the Anatomic Pathology Landscape

    • PHC Holdings Corporation
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Indica Labs, Inc.
    • F. Hoffmann-La Roche Ltd.
    • Laboratory Corporation of America Holdings
    • Quest Diagnostics Incorporated
    • Sakura Finetek USA, Inc.
    • Cardinal Health, Inc.
    • BioGenex
    • NeoGenomics Laboratories, Inc.
    • Agilent Technologies, Inc. 

Browse Key Market Insights with Data Illustration:

In the News

  • Epredia, - a subsidiary of PHC Holdings Corporation announced that its parent company has acquired anatomical pathology suppliers Laurypath and Microm Microtech France (MMFrance) to mark strategic expansion of Epredia’s presence in Europe.

  •  Indica Labs, Inc., - with The Industrial Centre for Artificial Intelligence Research in Digital Diagnostics(iCAIRD), announced an agreement to collaborate on the development of an AI-based digital pathology solution. The pathology will assist the detection of cancer within lymph nodes from colorectal surgery cases.


Author Credits:  Radhika Pawar


  • Report ID: 4377
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of anatomic pathology is evaluated at USD 41.1 billion.

The anatomic pathology market size was valued at USD 38.48 billion in 2024 and is anticipated to exceed USD 108.01 billion by the end of 2037, registering over 8.4% CAGR during the forecast period i.e., between 2025-2037. Increasing number of laboratory tests as well as biopsies performed along with rising cases of cancer, kidney diseases and others will propel the market growth.

North America industry will hold a share of 38% by 2037, backed by presence of a strong healthcare network in the region.

The major players in the market include PHC Holdings Corporation, Indica Labs, Inc., F. Hoffmann-La Roche Ltd., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Sakura Finetek USA, Inc., Cardinal Health, Inc., BioGenex, NeoGenomics Laboratories, Inc., Agilent Technologies, Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample